{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:03:39Z","timestamp":1773691419908,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004351","name":"Sultan Qaboos University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004351","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","brainanddevelopment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.braindev.2018.07.015","type":"journal-article","created":{"date-parts":[[2018,8,2]],"date-time":"2018-08-02T19:00:59Z","timestamp":1533236459000},"page":"57-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Atypical PEX16 peroxisome biogenesis disorder with mild biochemical disruptions and long survival"],"prefix":"10.1016","volume":"41","author":[{"given":"Nuha Al","family":"Zaabi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anoud","family":"Kendi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Al-Jasmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Shimozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama Y.","family":"Al-Dirbashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2018.07.015_b0005","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.bbadis.2012.04.006","article-title":"Genetics and molecular basis of human peroxisome biogenesis disorders","volume":"1822","author":"Waterham","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.braindev.2018.07.015_b0010","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.bbamcr.2015.12.005","article-title":"Peroxisomes in brain development and function","volume":"1863","author":"Berger","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.braindev.2018.07.015_b0015","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.bbamcr.2015.11.015","article-title":"Human disorders of peroxisome metabolism and biogenesis","volume":"1863","author":"Waterham","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.braindev.2018.07.015_b0020","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1042\/bst0290250","article-title":"Peroxisomal fatty acid alpha- and beta-oxidation in humans: enzymology, peroxisomal metabolite transporters and peroxisomal diseases","volume":"29","author":"Wanders","year":"2001","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.braindev.2018.07.015_b0025","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ymgme.2015.12.009","article-title":"Peroxisome biogenesis disorders in the Zellweger spectrum: an overview of current diagnosis, clinical manifestations, and treatment guidelines","volume":"117","author":"Braverman","year":"2016","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.braindev.2018.07.015_b0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ddrr.1113","article-title":"Peroxisome biogenesis disorders: biological, clinical and pathophysiological perspectives","volume":"17","author":"Braverman","year":"2013","journal-title":"Dev Disabil Res Rev"},{"key":"10.1016\/j.braindev.2018.07.015_b0035","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ymgme.2005.02.007","article-title":"An overview of peroxisomal biogenesis disorders","volume":"84","author":"Oglesbee","year":"2005","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.braindev.2018.07.015_b0040","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ajmg.a.20661","article-title":"Metabolic and molecular basis of peroxisomal disorders: a review","volume":"126A","author":"Wanders","year":"2004","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.braindev.2018.07.015_b0045","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ajmg.a.20664","article-title":"Peroxisome biogenesis disorders with prolonged survival: phenotypic expression in a cohort of 31 patients","volume":"126A","author":"Poll-The","year":"2004","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.braindev.2018.07.015_b0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/8904_2011_102","article-title":"Zellweger Spectrum Disorder with Mild Phenotype Caused by PEX2 Gene Mutations","volume":"6","author":"Mignarri","year":"2012","journal-title":"JIMD Rep"},{"key":"10.1016\/j.braindev.2018.07.015_b0055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-1172-6-8","article-title":"Autosomal recessive cerebellar ataxia caused by mutations in the PEX2 gene","volume":"6","author":"Sevin","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.braindev.2018.07.015_b0060","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.braindev.2012.10.017","article-title":"Newly identified milder phenotype of peroxisome biogenesis disorder caused by mutated PEX3 gene","volume":"35","author":"Matsui","year":"2013","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2018.07.015_b0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/8904_2016_10","article-title":"Novel PEX3 gene mutations resulting in a moderate zellweger spectrum disorder","volume":"34","author":"Maxit","year":"2017","journal-title":"JIMD Rep"},{"key":"10.1016\/j.braindev.2018.07.015_b0070","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s00415-016-8167-3","article-title":"Expanding the spectrum of PEX10-related peroxisomal biogenesis disorders: slowly progressive recessive ataxia","volume":"263","author":"Renaud","year":"2016","journal-title":"J Neurol"},{"key":"10.1016\/j.braindev.2018.07.015_b0075","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13256-017-1365-5","article-title":"Identification of a novel mutation in PEX10 in a patient with attenuated Zellweger spectrum disorder: a case report","volume":"11","author":"Blomqvist","year":"2017","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.braindev.2018.07.015_b0080","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10038-007-0157-y","article-title":"A novel PEX12 mutation identified as the cause of a peroxisomal biogenesis disorder with mild clinical phenotype, mild biochemical abnormalities in fibroblasts and a mosaic catalase immunofluorescence pattern, even at 40 degrees C","volume":"52","author":"Zeharia","year":"2007","journal-title":"J Hum Genet"},{"key":"10.1016\/j.braindev.2018.07.015_b0085","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/jmg.2009.074302","article-title":"Identification of an unusual variant peroxisome biogenesis disorder caused by mutations in the PEX16 gene","volume":"47","author":"Ebberink","year":"2010","journal-title":"J Med Genet"},{"key":"10.1016\/j.braindev.2018.07.015_b0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ymgmr.2015.09.001","article-title":"A homozygous mutation in PEX16 identified by whole-exome sequencing ending a diagnostic odyssey","volume":"5","author":"Bacino","year":"2015","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.braindev.2018.07.015_b0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4172\/2165-7920.1000854","article-title":"A Novel Mutation of the PEX16 Gene in a Patient with Slowly Progressive Zellweger Syndrome","volume":"6","author":"Ersoy","year":"2016","journal-title":"J Clin Case Rep"},{"key":"10.1016\/j.braindev.2018.07.015_b0100","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1083\/jcb.200601036","article-title":"The origin and maintenance of mammalian peroxisomes involves a de novo PEX16-dependent pathway from the ER","volume":"173","author":"Kim","year":"2006","journal-title":"J Cell Biol"},{"key":"10.1016\/j.braindev.2018.07.015_b0105","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0387-7604(03)00033-0","article-title":"Gas chromatography\/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders","volume":"25","author":"Takemoto","year":"2003","journal-title":"Brain Dev"},{"key":"10.1016\/j.braindev.2018.07.015_b0110","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1126\/science.1546315","article-title":"A human gene responsible for Zellweger syndrome that affects peroxisome assembly","volume":"255","author":"Shimozawa","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.braindev.2018.07.015_b0115","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF00219334","article-title":"Complementation study of peroxisome-deficient disorders by immunofluorescence staining and characterization of fused cells","volume":"88","author":"Yajima","year":"1992","journal-title":"Hum Genet"},{"key":"10.1016\/j.braindev.2018.07.015_b0120","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3181","article-title":"The peroxisome biogenesis disorders","author":"Gould","year":"2001"},{"key":"10.1016\/j.braindev.2018.07.015_b0125","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ymgme.2004.08.008","article-title":"The PEX Gene Screen: molecular diagnosis of peroxisome biogenesis disorders in the Zellweger syndrome spectrum","volume":"83","author":"Steinberg","year":"2004","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.braindev.2018.07.015_b0130","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1006\/bbrc.2002.6642","article-title":"A novel aberrant splicing mutation of the PEX16 gene in two patients with Zellweger syndrome","volume":"292","author":"Shimozawa","year":"2002","journal-title":"BiochemBiophys Res Commun"},{"key":"10.1016\/j.braindev.2018.07.015_b0135","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1086\/302161","article-title":"Mutation in PEX16 is causal in the peroxisome-deficient Zellweger syndrome of complementation group D","volume":"63","author":"Honsho","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.braindev.2018.07.015_b0140","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1399-0004.2010.01498.x","article-title":"Clinical, biochemical and molecular characterization of peroxisomal diseases in Arabs","volume":"79","author":"Shaheen","year":"2011","journal-title":"Clin Genet"},{"key":"10.1016\/j.braindev.2018.07.015_b0145","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00431-014-2431-2","article-title":"Zellweger syndrome and secondary mitochondrial myopathy","volume":"174","author":"Salpietro","year":"2015","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.braindev.2018.07.015_b0150","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10048-013-0375-8","article-title":"Diagnostic utility of whole exome sequencing in patients showing cerebellar and\/or vermis atrophy in childhood","volume":"14","author":"Ohba","year":"2013","journal-title":"Neurogenetics"},{"key":"10.1016\/j.braindev.2018.07.015_b0155","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/088307389901400705","article-title":"Diagnosis and follow-up of a case of peroxisomal disorder with peroxisomal mosaicism","volume":"14","author":"Pineda","year":"1999","journal-title":"J Child Neurol"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760418302316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760418302316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T17:53:10Z","timestamp":1543945990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760418302316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0387760418302316"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2018.07.015","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atypical PEX16 peroxisome biogenesis disorder with mild biochemical disruptions and long survival","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2018.07.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Japanese Society of Child Neurology Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}